微创妇科手术加速康复路径实施后住院预测因素
本研究为前瞻性观察性研究,纳入165例在加速康复外科(ERAS)路径下接受腹腔镜或机器人辅助子宫切除术的良性适应症女性,旨在识别术后住院的预测因素。结果显示56%患者手术当日出院,术后尿潴留和疼痛控制不佳是最常见住院原因;ASA分级III、非裔美国人及手术时间延长与住院风险增加独立相关。当日出院与住院患者在90天内急诊就诊、再入院和再手术率无显著差异。
要点
- ASA III级、非裔美国人及手术时间每延长30分钟与住院风险增加独立相关。
- 术后尿潴留和疼痛控制不佳各占住院原因的30%。
- 当日出院与住院患者的90天再入院、再手术和急诊就诊率无差异。
核心结论
- ASA分级增高、非裔美国人及手术时间延长是ERAS路径下腹腔镜或机器人辅助子宫切除术后住院的显著预测因素。
- 当日出院与住院患者的90天内急诊就诊、再入院和再手术发生率相似。
研究设计与样本
- 前瞻性观察性研究,纳入165例良性适应症在ERAS路径下接受腹腔镜或机器人辅助子宫切除术的女性。
主要发现
- 165例中93例(56%)手术当日出院,72例住院。
- 住院最常见原因为术后尿潴留(n=21,30%)、疼痛控制不佳(n=21,30%)、术后恶心呕吐(n=7,10%)和计划住院(n=7,10%)。
临床怎么用
- 对ASA III级、非裔美国人或手术时间较长的患者,应加强术后尿潴留和疼痛管理以降低住院风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Enhanced recovery after surgery (ERAS) pathways in gynecologic surgery have been shown to decrease length of stay with no impact on readmission, but no study has assessed predictors of admission in this population. The purpose of this study was to identify predictors of admission after laparoscopic hysterectomy (LH) and robotic-assisted hysterectomy (RAH) performed under an ERAS pathway. METHODS: This is a prospective observational study of women undergoing LH/RAH for benign indications within an ERAS pathway. Data collected included same-day discharge, reason for admission, incidences of urgent clinic and emergency room (ER) visits, readmissions, reoperations, and 9 postulated predictors of admission listed below. Patient demographics, markers of baseline health, and clinical outcomes were compared between groups (ERAS patients discharged on the day of surgery versus admitted) using Fisher exact and Student t tests. Multivariable logistic regression was used to assess the potential risk factors for being admitted, adjusting for age, race, body mass index, American Society of Anesthesiologists (ASA) physical status score, preoperative diagnosis indicative of hysterectomy, preoperative chronic pain, completion of a preprocedure pain-coping skills counseling session, procedure time, and compliance to the ERAS pathway. RESULTS: There were 165 patients undergoing LH/RAH within an ERAS pathway; 93 (56%) were discharged on the day of surgery and 72 were admitted. There were no significant differences in ER visits, readmissions, and reoperations between groups (ER visits: discharged 13% versus admitted 13%, P = .99; 90-day readmission: discharged 4% versus admitted 7%, P = .51; and 90-day reoperation: discharged 4% versus admitted 3%, P = .70). The most common reasons for admission were postoperative urinary retention (n = 21, 30%), inadequate pain control (n = 21, 30%), postoperative nausea and vomiting (n = 7, 10%), and planned admissions (n = 7, 10%). Increased ASA physical status, being African American, and increased length of procedure were significantly associated with an increased risk of admission (ASA physical status III versus ASA physical status I or II: odds ratio [OR], 3.12; 95% confidence interval [CI], 1.36-7.16; P = .007; African American: OR, 2.47; 95% CI, 1.02-5.96; P = .04; and length of procedure, assessed in 30-minute increments: OR, 1.23; 95% CI, 1.02-1.50; P = .04). CONCLUSIONS: We were able to define predictors of admission for patients having LH/RAH managed with an ERAS pathway. Increased ASA physical status, being African American, and increased length of procedure were significantly associated with admission after LH/RAH performed under an ERAS pathway. In addition, the incidences of urgent clinic and ER visits, readmissions, and reoperations within 90 days of surgery were similar for patients who were discharged on the day of surgery compared to those admitted.
引用
- Keil DS, Schiff LD, Carey ET, et al. Predictors of Admission After the Implementation of an Enhanced Recovery After Surgery Pathway for Minimally Invasive Gynecologic Surgery. Anesth Analg. 2019. PMID: 31425219. doi:10.1213/ANE.0000000000003339
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。